(19)
(11) EP 0 870 198 A1

(12)

(43) Date of publication:
14.10.1998 Bulletin 1998/42

(21) Application number: 96904515.0

(22) Date of filing: 25.01.1996
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 31/ 70( . )
A61K 48/ 00( . )
C07H 21/ 04( . )
C07K 14/ 72( . )
C12N 5/ 10( . )
C12P 21/ 02( . )
C12Q 1/ 68( . )
G01N 33/ 53( . )
A61K 38/ 00( . )
 A61K 31/ 00( . )
A61K 31/ 7088( . )
A61P 43/ 00( . )
C07K 7/ 02( . )
C07K 16/ 28( . )
C12N 15/ 00( . )
C12P 21/ 08( . )
G01N 33/ 15( . )
G01N 33/ 566( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1996/001179
(87) International publication number:
WO 1996/023225 (01.08.1996 Gazette 1996/35)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 25.01.1995 US 19950390301

(71) Applicant: COR THERAPEUTICS, INC.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • SUNDELIN, Johan
    S-244 65 Furulund (SE)
  • SCARBOROUGH, Robert, M.
    Belmont, CA 94002 (US)

(74) Representative: Jacquard, Philippe Jean-Luc, et al 
CABINET ORES, 6, Avenue de Messine
75008 Paris
75008 Paris (FR)

   


(54) RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR